AbbVie Goodwill and Intangible Assets 2010-2024 | ABBV

AbbVie goodwill and intangible assets for the quarter ending December 31, 2024 were $101.941B, a 12.4% increase year-over-year.

  • AbbVie goodwill and intangible assets for 2024 were $95.024B, a 8.1% increase from 2023.
  • AbbVie goodwill and intangible assets for 2023 were $87.903B, a 11.74% decline from 2022.
  • AbbVie goodwill and intangible assets for 2022 were $99.595B, a 8.06% decline from 2021.

AbbVie Goodwill and Intangible Assets 2010-2024 | ABBV

  • AbbVie goodwill and intangible assets for 2024 were $95.024B, a 8.1% increase from 2023.
  • AbbVie goodwill and intangible assets for 2023 were $87.903B, a 11.74% decline from 2022.
  • AbbVie goodwill and intangible assets for 2022 were $99.595B, a 8.06% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B